Search results for "Science" in Articles / App Notes
Article
Bioburden Control in the Biopharmaceutical Industry
Pharmaceutical Science and Technology 58 (4), 231-237 (2004).
14. M. Eissa, M. Seif, and M. Fares, Int. J. Qual. Assur. 6 (2), 54-72 (2015).
15. M.E. Eissa, A.M. Mahmoud, and A.S. Nouby, D…
Article
Managing Residual Impurities During Downstream Processing
The scientific and technical fields are evolving, agrees Bérangère Tissot, general manager of SGS’s Life Science laboratory in West Chester, PA, and the number and diversity of biologic drug substance…
Article
Being Thorough When Transferring Technology
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics.
By Susan Haigney
Editor's note: The following is an extended version of the…
Article
Cost Considerations Drive Lean Technology in Biopharmaceutical Manufacturing
Adam Elhofy, chief science officer for Essential Pharmaceuticals, has worked with innovator biopharmaceutical companies as well as biosimilar companies. “Biosimilars are constrained in that they have …
Article
Single-use Bioreactors Have Reached the Big Time
…ve, according to Annelies Onraedt, director of marketing for cell culture technologies at Pall Life Sciences. “When considering the workflow and objectives of running bioreactors, recent developments…
Article
Reconciling Sensor Communication Gaps
…t include tubing, bags, sensors, devices, and connectors,” says Michalle Adkins, director of life sciences consulting at Emerson Automation Solutions (Pittsburgh, PA).cleaning validation, and calibra…
Article
Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution
Perkins, PhD currently at the Department of Manufacturing Science and Technology, Hospira, USA for her feedback.
REFERENCES
1. T.K. Das, AAPS PharmSciTech. 13 (2), pp. 732-746 (201…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
2016 Global Life Sciences Outlook, Moving Forward With Cautious Optimism, Deloitte, https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-life-sciences…
Article
Biosimilars to Drive Modern Manufacturing Approaches
FDA’s regulation of biosimilars is “under the microscope” in Washington, she noted, but “great science” and “fit-for-purpose, innovative regulation” will support patient access to these more affordabl…
Article
Protein Characterization Using SEC: Three Webinar Takeaways
With more than thirty years in protein science, Åke Danielsson, Research Director at Cytiva, recently held a webinar on protein characterization using size exclusion chromatography (SEC). Here, …